In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEDICLE BONE SCREW CLASS ACTION STATUS WILL BE CONSIDERED

This article was originally published in The Gray Sheet

Executive Summary

PEDICLE BONE SCREW CLASS ACTION STATUS WILL BE CONSIDERED in combined pretrial conference and hearings beginning Oct. 4 under Justice Louis Bechtle of the Eastern District of Pennsylvania. Bechtle will hear arguments in Zampirri et al. vs. AcroMed and Sofamor/Danek Group, the first federal complaint filed that seeks class status. If Bechtle certifies the suit as a class action, the approximately 50 federal suits filed to date could be incorporated, according to plaintiffs' lawyers.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel